Filing Details
- Accession Number:
- 0001570523-18-000004
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-28 18:47:47
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-28 18:47:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Transaction Summary
| Purchased: | 85,800 shares | Avg. Price: $0.04 | Total Value: $3,689.00 |
| Number of Shares After Transactions: | 22,059,859 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-24 | 200 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-20 | 300 | $0.03 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-20 | 200 | $0.03 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-22 | 1,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-22 | 100 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-23 | 15,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-29 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-29 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-29 | 2,820 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-29 | 10,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-29 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-30 | 7,180 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 5,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 15,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 1,250 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 3,750 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-03 | 1,250 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-03 | 750 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-03 | 2,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-05 | 1,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-12 | 1,250 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-12 | 3,750 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-12 | 1,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-12 | 1,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-12 | 3,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-12 | 2,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-12 | 1,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-13 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-13 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-13 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
